The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1476
ISSUE1476
August 31, 2015
ReShape and Orbera - Two Gastric Balloon Devices for Weight Loss
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
ReShape and Orbera - Two Gastric Balloon Devices for Weight Loss
August 31, 2015 (Issue: 1476)
The FDA has approved the ReShape Integrated Dual
Balloon System (ReShape Medical) and the Orbera
Intragastric Balloon System (Apollo Endosurgery) for
up to 6 months of use in adults with a BMI of 30-40
who have not been able to maintain weight...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.